British drugmaker AstraZeneca <AZN.L> said on Saturday its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of COVID-19, based on early data from a trial.
AstraZeneca shot less effective vs S African variant bworldonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bworldonline.com Daily Mail and Mail on Sunday newspapers.
AstraZeneca has said its vaccine, developed with the University of Oxford, appeared to offer only limited protection against mild disease caused by the South African variant of Covid-19, based on early data from a trial.